3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
2
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pseudomyxoma Peritonei
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Melanoma
1
Lymphoma, B-Cell
1
Lymphoma
1
Kidney Transplantation
1
Digestive System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Adenocarcinoma, Clear Cell
1
Interventions
fludarabine
7
Cyclophosphamide
6
fludarabine phosphate
5
Melphalan
4
thymoglobulin
3
Tacrolimus
3
Methotrexate
3
Cytarabine
3
Busulfan
3
trametinib
2
blinatumomab
2
Whole-Body Irradiation
2
Transplantation
2
Thiotepa
2
Specimen Handling
2
Sirolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Mesna
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Biopsy
2
Azacitidine
2
omipalisib
1
merphos
1
imetelstat
1
hydrocortisone hemisuccinate
1
Vorinostat
1
Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Juvenile
×
Alemtuzumab
×
1 year
×
Clear all
No trials found.